Adenoviral-mediated transfer of human BMP-6 gene accelerates healing in a rabbit ulnar osteotomy model

被引:81
作者
Bertone, AL
Pittman, DD
Bouxsein, ML
Li, J
Clancy, B
Seeherman, HJ
机构
[1] Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA
[2] Womens Hlth & Bone Wyeth Res, Cambridge, MA USA
[3] Cardiovasc & Metab Dis Wyeth Res, Cambridge, MA USA
关键词
gene therapy; fracture healing; BMP; rabbit osteotomy;
D O I
10.1016/j.orthres.2004.03.014
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
This study evaluated healing of rabbit bilateral ulnar osteotomies 6 and 8 weeks after surgery in response to percutaneous injection of transgenic adenoviral (Ad) bone morphogenetic protein-6 (BMP-6) vector or green fluorescent protein vector control (Ad-GFP) administered 7 days after surgery compared to untreated osteotomy controls. The amount, composition and biomechanical properties of the healing bone repair tissue were compared among groups and to historical data for intact rabbit ulnae obtained from similar studies at the same institution. Quantitative computed tomography was used to determine area, density and mineral content of the mineralized callus in the harvested ulnae. Maximum torque, torsional stiffness, and energy absorbed to failure were determined at 1.5degrees/s. Calcified sections of excised ulnae (5 mum) were stained with Goldner's Trichrome and Von Kossa, and evaluated for callus composition, maturity, cortical continuity, and osteotomy bridging. Radiographic assessment of bone formation indicated greater mineralized callus in the ulnae injected with Ad-hBMP-6 as early as 1 week after treatment (2 weeks after surgery) compared to untreated osteotomy ulnae (p < 0.006) and Ad-GFP treated osteotomy ulnae (p < 0.002). Quantitative computed tomography confirmed greater bone area and bone mineral content at the osteotomy at 6 weeks in Ad-BMP-6 treated osteotomy as compared to untreated osteotomy ulnae (p < 0.001) and Ad-GFP treated osteotomy ulnae (p < 0.01). Ad-BMP-6 treated osteotomy ulnae were stronger (p < 0.001 and 0.003) and stiffer (p = 0.004 and 0.003) in torsion at 6 weeks than untreated osteotomy ulnae or Ad-GFP treated osteotomy ulnae, respectively. Maximum torque, torsional stiffness, and energy absorbed to failure were greater in Ad-BMP-6 treated osteotomy ulnae compared to their respective untreated contralateral osteotomy ulnae at 8 weeks [p < 0.03]. Maximum torque and torsional stiffness in the Ad-BMP-6 treated osteotomy ulnae were not different to intact ulnae values at 6 and 8 weeks. These experiments confirm that BMP-6 can be potently osteoinductive in vivo resulting in acceleration of bone repair. (C) 2004 Orthopaedic Research Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1261 / 1270
页数:10
相关论文
共 71 条
[1]   Enhancement of bone repair with a helper-dependent adenoviral transfer of bone morphogenetic protein-2 [J].
Abe, N ;
Leea, YP ;
Sato, M ;
Zhang, XG ;
Wu, J ;
Mitani, K ;
Lieberman, JR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 297 (03) :523-527
[2]   Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion [J].
Akamaru, T ;
Suh, D ;
Boden, SD ;
Kim, HS ;
Minamide, A ;
Louis-Ugbo, J .
SPINE, 2003, 28 (05) :429-434
[3]   Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy [J].
Alden, TD ;
Pittman, DD ;
Beres, EJ ;
Hankins, GR ;
Kallmes, DF ;
Wisotsky, BM ;
Kerns, KM ;
Helm, GA .
JOURNAL OF NEUROSURGERY, 1999, 90 (01) :109-114
[4]   In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector [J].
Alden, TD ;
Pittman, DD ;
Hankins, GR ;
Beres, EJ ;
Engh, JA ;
Das, S ;
Hudson, SB ;
Kerns, KM ;
Kallmes, DF ;
Helm, GA .
HUMAN GENE THERAPY, 1999, 10 (13) :2245-2253
[5]   The use of bone morphogenetic protein gene therapy in craniofacial bone repair [J].
Alden, TD ;
Beres, EJ ;
Laurent, JS ;
Engh, JA ;
Das, S ;
London, SD ;
Jane, JA ;
Hudson, SB ;
Helm, GA .
JOURNAL OF CRANIOFACIAL SURGERY, 2000, 11 (01) :24-30
[6]   Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene [J].
Baltzer, AWA ;
Lattermann, C ;
Whalen, JD ;
Wooley, P ;
Weiss, K ;
Grimm, M ;
Ghivizzani, SC ;
Robbins, PD ;
Evans, CH .
GENE THERAPY, 2000, 7 (09) :734-739
[7]   A gene therapy approach to accelerating bone healing - Evaluation of gene expression in a New Zealand white rabbit model [J].
Baltzer, AWA ;
Lattermann, C ;
Whalen, JD ;
Braunstein, S ;
Robbins, PD ;
Evans, CH .
KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, 1999, 7 (03) :197-202
[8]   Growth factor regulation of fracture repair [J].
Barnes, GL ;
Kostenuik, PJ ;
Gerstenfeld, LC ;
Einhorn, TA .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (11) :1805-1815
[9]   LMP-1, a LIM-domain protein, mediates BMP-6 effects on bone formation [J].
Boden, SD ;
Liu, YS ;
Hair, GA ;
Helms, JA ;
Hu, D ;
Racine, M ;
Nanes, MS ;
Titus, L .
ENDOCRINOLOGY, 1998, 139 (12) :5125-5134
[10]   Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans - A prospective, randomized clinical pilot trial - 2002 Volvo Award in clinical studies [J].
Boden, SD ;
Kang, J ;
Sandhu, H ;
Heller, JG .
SPINE, 2002, 27 (23) :2662-2673